Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 26;17(1):41-55.
doi: 10.1016/j.chmed.2024.11.010. eCollection 2025 Jan.

A comprehensive review of phytochemical approaches in treatment of acute myeloid leukemia: Associated pathways and molecular mechanisms

Mouvanal Sajana  1 , T S Gopenath  2 , Basalingappa M Kanthesh  1
Affiliations
Review

A comprehensive review of phytochemical approaches in treatment of acute myeloid leukemia: Associated pathways and molecular mechanisms

Mouvanal Sajana et al. Chin Herb Med. .

Abstract

Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. This review conducts a thorough analysis of AML, addressing its genetic modification. The examination extends to the current therapeutic approaches employed for AML, shedding light on their efficacy and the notable side effects experienced by patients undergoing these treatments, leading to a low overall survival rate. Therefore, exploring alternative treatments, such as phytochemicals, is necessary. Furthermore, the review explores the complex landscape of phytochemicals, categorizing them based on their diverse properties, which include alkaloids, phenols, terpenoids, organo-sulfur compounds, and other compounds, including quinones, and elucidating their mechanisms of action. Special emphasis is placed on their involvement in critical signaling pathways, with a particular focus on how these phytochemicals impact AML when evaluated across a spectrum of cell lines. This in-depth exploration aims to uncover potential targets within the molecular landscape of AML where phytochemicals can exert their therapeutic effects. The review investigates the potential role of plant-derived phytochemicals as adjunctive therapies for AML. This exploration encompasses the identification of specific phytochemicals that exhibit promising anti-leukemic properties and evaluates their potential in clinical settings. Beyond conventional treatments, the review explores the integration of complementary and alternative medicine as a holistic approach to managing AML. The examination encompasses the synergy between conventional therapies and alternative interventions, exploring how these combined strategies may enhance overall therapeutic outcomes and mitigate side effects. From a forward-looking perspective, the overarching goal is to contribute to the evolving landscape of AML treatment by considering innovative approaches that harness the therapeutic potential of phytochemicals, both independently and in conjunction with established medical interventions.

Keywords: cell death; complementary and alternative medicine; leukemia; phytochemicals; signaling pathways; therapeutic targets.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Common mutations in acute myeloid leukemia.
Fig. 2
Fig. 2
Common drugs used in the treatment of AML and associated side effects.
See this image and copyright information in PMC

References

    1. Adan A., Baran Y. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks. Tumour Biology. 2015;36(11):8973–8984. - PubMed
    1. Al-Abbas N.S., Shaer N.A. Combination of coumarin and doxorubicin induces drug-resistant acute myeloid leukemia cell death. Heliyon. 2021;7(3) - PMC - PubMed
    1. Alhuthali H.M., Bradshaw T.D., Lim K.H., Kam T.S., Seedhouse C.H. The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun. BMC Cancer. 2020;20(1):629. - PMC - PubMed
    1. Arber D.A., Orazi A., Hasserjian R.P., Borowitz M.J., Calvo K.R., Kvasnicka H.M., Wang S.A., Bagg A., Barbui T., Branford S., Bueso-Ramos C.E., Cortes J.E., Cin P.D., DiNardo C.D., Dombret H., Duncavage E.J., Ebert B.L., Estey E.H., Facchetti F.…Tefferi A. International consensus classification of myeloid neoplasms and acute leukemias: Integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. - PMC - PubMed
    1. Bhansali R.S., Pratz K.W., Lai C. Recent advances in targeted therapies in acute myeloid leukemia. Journal of Hematology & Oncology. 2023;16(1):29. - PMC - PubMed

LinkOut - more resources